Jeffrey Cummings (Brain Health) co-authored a paper published in Nature on developing the ATX(N) classification, a system for recognizing biomarkers in blood that indicate the presence in the brain of plaques and tangles characteristic of Alzheimer’s disease. ATX(N) advances allow researchers to diagnose Alzheimer’s disease without imaging or autopsy; the tests may soon become available for clinical use. Cummings is part of the Chambers-Grundy Center for Transformative Neuroscience at UNLV.
Share your thoughts about this story. To comment, you'll need to login into your Facebook account. Your comment will post immediately. Comments that are not in keeping with our comment policies may be removed by editors.